Leadership Team
Michael Rabinowitz
Chairman and Chief Executive Officer
Edward L. Rose
Vice Chairman and Special Counsel
Christopher J. Fiore
Co-President
Clifford A. Teller
Co-President
Executive Team
Timothy G. Murphy
Chief Financial Officer
John Sergio
Chief Operating Officer
James Siegel
General Counsel
Tipton Evans
Chief Compliance Officer
Anthony V. Vendetti
Executive Managing Director of Research
Chris Brothers
Executive Managing Director of Merchant Capital
John Michaels
Chief Technology Officer & Chief Information Security Officer
Franco Zappone
Executive Managing Director
Anthony DiClemente
Chief Administrative Officer
Business Teams
Latest Maxim Group News
Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today
June 9, 2023
Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today
June 9, 2023
Beneficient – a Financial Technology-Enabled Institution – Lists Shares Upon Successful Merger
Beneficient (“Ben,” “Beneficient” or the “Company”), a technology-enabled platform providing liquidity and related trust and
June 9, 2023
